Background/objective: Chondrogenesis is an integral part of endochondral bone formation, by which the midline cranial base is developed. Reactive oxygen species (ROS) are required in chondrogenic differentiation and antioxidant enzymes regulate their levels. The aim of this study was to localize the antioxidant enzyme glutathione peroxidase 1 (Gpx1) at the spheno-occipital synchondrosis, as well as its effect on ROS challenge and its expression pattern in the course of differentiation. Materials and methods: Gpx1 was semiquantified in immunohistochemically stained sections of spheno-occipital synchondroses of rats. The effect of Gpx1 on ROS-induced apoptosis was investigated by manipulating the expression of Gpx1 in ATDC5 cells. The temporal pattern of Gpx1 expression was determined during chondrocyte differentiation for 21 days in vitro. Results: Proliferating chondrocytes exhibited the greatest Gpx1 immunoreactivity and hypertrophic ones the lowest (P = 0.02). Cells transfected with Gpx1-siRNA had the highest apoptotic rate, while cells overexpressing Gpx1 the lowest one (P < 0.001). Gpx1 was significantly increased on days 10 (P = 0.02) and 14 (P = 0.01). Conclusions: Hypertrophic chondrocytes have the lowest Gpx1 activity in the spheno-occipital synchondrosis. Gpx1 is implicated in the ROS-induced apoptosis in chondrocytes. Its expression was not constitutive during chondrogenic differentiation.
Introduction
The development and growth of the cranial base strongly affects the craniofacial development and facial morphology. This is reflected in a range of craniofacial abnormalities demonstrating characteristic facial morphologies, where underlying abnormalities of the cranial base have been documented in both clinical and animal studies (1) (2) (3) (4) (5) (6) (7) . As far as the skeletal malocclusions are concerned, the anteroposterior relationship of the jaws seems to be related with the length and angulation of the cranial base (8) (9) (10) (11) (12) (13) (14) .
The cranial base growth plate is considered an important area of growth, especially the spheno-occipital synchondrosis (15) . Specifically, it significantly contributes to angulation and antero-posterior growth (16) (17) (18) via interstitial growth of a pressure-adapted Antioxidant enzymes can efficiently reduce ROS. They are both a defence against oxidative damage (26) and regulators of local levels of ROS needed to trigger various biological responses (27) (28) (29) . Glutathione peroxidases are a family of antioxidant enzymes that can efficiently reduce H 2 O 2 and also participate in important biological contexts (30) . Among them, glutathione peroxidase 1 (Gpx1) is a widely distributed intracellular protein, ubiquitously present in all cells (31) . However, Gpx1 has not been identified at the cranial base growth plate. In addition, its relationship with oxidative stress remains unclear in chondrocytes. Thus, this study aims to identify and localize the expression of Gpx1 at the spheno-occipital synchondrosis, and investigate the association of Gpx1 with oxidative challenge in chondrocytes as well as the temporal pattern of its expression during differentiation in vitro.
Materials and methods

Tissue collection and immunohistochemistry
Eight newborn male Wistar rats were decapitated and their neurocrania were transversally dissected. After the brain was removed, the spheno-occipital synchondrosis was isolated ( Figure 1A ) and fixed in 4% neutral buffered formaldehyde. Tissues were decalcified and subsequently embedded in paraffin. Tris-ethylenediaminetetraacetic acid buffer antigen retrieval was performed followed by blocking of non-specific binding sites with Peroxidase Blocking Reagent (DAKO, Carpinteria, California, USA). Sections were incubated with anti-Gpx1 primary monoclonal antibody (1:250; ab108427; Abcam, Cambridge, UK). Goat anti-rabbit antibody conjugated with horseradish peroxidase (611-1302; Rockland Immunochemicals, Gilbertsville, Pennsylvania, USA) was then applied and diaminobenzidine chromogenic substrate was used for detection. Negative controls included sections that were incubated without the primary or secondary antibodies.
Photographs of the immunostained sections were analyzed at ×200 magnification factor to localize Gpx1 at the spheno-occipital synchondrosis. Immunoreactivity of Gpx1 was semiquantitatively determined by two independent observers who assigned one of the following grades to resting, proliferating, and hypertrophic zones ( Figure 1B ): 0, no immunoreactivity; 1, weak immunoreactivity (<25% of the cells); 2, moderate immunoreactivity (25-50% of the cells); 3, strong immunoreactivity (50-75% of the cells); and 4, very strong immunoreactivity (>75% of the cells). Multiple sections were analyzed per specimen and the median of replicates was then considered. Repeatability was assessed by analyzing randomly selected photographs with an interval of a week.
Manipulation of Gpx1 expression
The expression of Gpx1 was transiently manipulated. The ATDC5 cell line was used, which is a suitable in vitro model to simulate chondrogenic differentiation analogous to that occurring during endochondral ossification in vivo (32, 33) . For the overexpression experiments, Gpx1 was amplified from the complementary DNA of ATDC5 cells. Cloning was performed with Phusion High-Fidelity PCR Kit (New England Biolabs, Beverly, Massachusetts, USA). The forward and reverse primers were 5′-caccatgtgtgctgctcggctct-3′ and 5′-ccttaggagttgccagactgc-3′, respectively. Cycling conditions were 98°C for 30 seconds, followed by 30 cycles at 98°C for 10 seconds, 60°C for 30 seconds and 72°C for 30 seconds, and a final extension of 72°C for 5 minutes. Extraction and purification of the PCR products was done with QIAquick Gel Extraction Kit (Qiagen GmbH, Hilden, Germany). The plasmid DNA was sequenced with Eurofins MWG Operon (Ebersberg, Germany) and the cloned sequence was found to be identical to the murine Gpx 1 (NM_008160).
The mammalian expression vectors pcDNA3.1D/V5-His-TOPO (Invitrogen, Carlsbad, California, USA) were transformed in Escherichia coli and the plasmid DNA was purified with NucleoBond Xtra Midi Plus (Macherey-Nagel, Düren, Germany) according to the manufacturer's protocol. Cells were transfected with Gpx1 or LacZ (control) plasmids in TurboFect Transfection Reagent (Thermo Scientific, Waltham, Massachusetts, USA) according to the manufacturer's instructions.
To knockdown Gpx1, siRNA transfections were performed with Trilencer-27 siRNA kit (OriGene, Rockville, Maryland, USA). Cells were transfected with 5 nM Gpx1-siRNA and scrambled RNA as negative control (SR405153; OriGene) according to the application guide. Both the overexpression and knockdown of Gpx1 were verified with quantitative reverser transcription-PCR (RT-PCR).
Exposure to H 2 O 2 and apoptosis assay
Transfected cells were incubated for 72 hours and then treated with 250 µM H 2 O 2 for 6 hours. Quantitative evaluation of cells undergoing apoptosis was done with FITC Annexin V Apoptosis Detection Kit I (BD Biosciences Pharmingen, San Diego, California, USA) according to the manufacturer's protocol. Measurements were performed with a BD FACSCanto Flow Cytometer (BD Biosciences, San Jose, California, USA).
Cell line and culture conditions
To observe the temporal expression pattern of Gpx1, quantitative RT-PCR was carried out on predetermined time points: on day 0, 2, 6, 10, 14, and 21. Cells were seeded in six-well plates at an inoculum size of 7 × 10 4 per well. Until the fifth day of culture (day 0), cells received the maintenance medium comprising 1:1 mixture of Dulbecco's modified Eagle's medium and Ham's F-12 supplemented with 5% fetal calf serum, 1% antibiotics and antimycotics, 10 µg/ ml human transferrin, and 3 × 10 −8 M sodium selenite. For the induction of chondrogenesis over the following 21 days, the maintenance medium was additionally supplemented with 10 µg/ml bovine insulin and 20 mg/ml ascorbic acid (34) . The medium was replaced every other day and cell cultures were maintained at 37°C under a humidified atmosphere of 5% CO 2 .
Isolation of total RNA, synthesis of cDNA and quantitative RT-PCR Cells were rinsed with 1 ml peqGOLD TriFast reagent (Peqlab Biotechnologie GmbH, Erlangen, Germany) and further processed according to the manufacturer's recommendations. For the subsequent cDNA synthesis, 1 µg of the total RNA was reverse-transcribed to complementary DNA with the QuantiTect® Reverse Transcriptase Kit (Qiagen GmbH). All quantitative RT-PCR reactions were performed in triplicates with a Mastercycler ep realplex (Eppendorf AG, Hamburg, Germany). For each pair of primers, negative controls were included. An extra step of melting curve was also included.
Collagen type II (Col2a1) and collagen type X (Col10a1) were used as chondrogenic gene markers corresponding to different stages of differentiation. Col2a1 is a well-established marker for the initial differentiation of chondrocytes, while Col10a1 is a marker for the terminal differentiation (22, 35) . Both of them have also been identified at the spheno-occipital synchondrosis (36) . The expression of polymerase II (Polr2a) was set as the endogenous control (Table 1) .
For the statistical analysis, the data were normalized against the endogenous control according to the formula ΔC t = C t endog. control − C t gene of interest . The mRNA levels normalized and relative to the endogenous control are presented as individual data points 2 ΔCt (37).
Stainings
For visualizing the process of chondrogenic differentiation, cells were stained with Alcian Blue 8 GS (Carl Roth GmbH, Karlsruhe, Germany) in order to reveal the synthesis of proteoglycans, while the Alizarin Red S (Carl Roth GmbH) revealed the mineralization of the extracellular matrix. Images of stained cells were recorded with Olympus IX50 (Olympus Optical Co., Hamburg, Germany). 
Statistical analysis
Results
Chondrogenic differentiation of ATDC5 cell line
The differentiation of chondrocytes in vitro was determined with the stainings Alcian Blue and Alizarin Red and the mRNA expression of chondrogenic biological markers. The production of proteoglycans and the calcification of extracellular matrix became more intense with the course of differentiation (Supplementary Figure 1A) . The expression of Col2a1 increased significantly on days 10 and 14. The expression of Col10a1, although not detectable at the beginning of differentiation, moderately increased on days 6 and 10 and became significantly increased on days 14 and 21 (Supplementary Figure 1B) .
Expression pattern of Gpx1 in vitro
For Gpx1 investigated on the predetermined days, there was a statistically significant difference in its levels of expression during the 21 days (N = 6, χ 2 (6) = 20.43, P < 0.01). Multiple comparisons identified a statistically significant increase relative to the endogenous control between the days 0 and 14 (P = 0.03), 2 and 10 (P = 0.02), and 2 and 14 (P = 0.01; Figure 2 ).
Hypertrophic chondrocytes demonstrate the lowest Gpx1 immunoreactivity
Cohen's kappa was 0.797 for the inter-observer agreement and the Wilcoxon signed-rank test for repeatability between the time points of evaluation was not significant (P = 0.56). The expression of Gpx1 at the spheno-occipital synchondrosis was found to be the highest in the proliferating zones, followed by the resting zones. The hypertrophic zones demonstrated the lowest Gpx1 immunoreactivity, which was statistically significant in comparison to the resting (N = 8, z = −2.64, P = 0.02) and proliferating zones (N = 8, z = −2.59, P = 0.02; Figure 3 ).
Gpx1-depleted chondrocytes undergo apoptosis
There was a statistically significant difference among groups as determined by Welch ANOVA (F(2, 9.25) = 3718.6, P < 0.001).
The Games-Howell post-hoc tests showed that the apoptotic rate of Gpx1-depleted chondrocytes was statistically significantly higher (66.1 ± 0.57 %, P < 0.001) than that of the control (17.7 ± 0.27 %). Furthermore, chondrocytes overexpressing Gpx1 had lower apoptotic rate (10.9 ± 0.22 %, P < 0.001) than Gpx1-depleted cells (66.1 ± 0.57 %, Figure 4 ).
Discussion
Although ROS have been better studied in regard to their cytotoxic effects, their semantic involvement in eukaryotic signal transduction is well established nowadays (27) (28) (29) . Just as ROS are required in several developmental processes (38) , so too is their role crucial in chondrogenesis. NADPH oxidases 2 and 4 generate ROS that are required for the early phase of differentiation (25) , while the elevation of ROS inhibits the proliferation and induces the hypertrophy of chondrocytes (24) . Provided that antioxidant enzymes play a key role on ROS degradation and subsequently on levels of oxidative state, we investigated the Gpx1 at the primary cartilage of spheno-occipital synchondroses in rats. We found that Gpx1 was present at the spheno-occipital synchondrosis and hypertrophic chondrocytes displayed the lowest immunoreactivity. Similar to our findings, lower activity of superoxide dismutase, glutathione peroxidase 4, and catalase has been reported for hypertrophic chondrocytes compared to other stages of chondrocyte differentiation (39, 40) . Collectively, these findings could explain the higher levels of ROS previously identified in pre-hypertrophic and hypertrophic chondrocytes as compared to those of proliferating ones (24) .
Provided that hypertrophic chondrocytes finally undergo apoptosis (22), we then manipulated the expression of Gpx1 in ATDC5 cells to confirm that this has an effect on ROS-induced apoptosis. Under exposure to H 2 O 2 , Gpx1-depleted chondrocytes had the highest apoptotic rate compared to that of control and chondrocytes overexpressing Gpx1. This indicates that Gpx1 exerts a regulatory influence on ROS levels and ROS-induced apoptosis in chondrocytes. However, Gpx1 is clearly not the only enzyme responsible for H 2 O 2 degradation. Nonetheless, the other source of H 2 O 2 degradation, catalase, was shown to be inactivated (41, 42) in the presence of high concentrations of H 2 O 2 . In addition, catalase seems to be dependent on Gpx1 activity to prevent its inactivation at high concentrations of H 2 O 2 (42) . These findings further underline the importance of Gpx1.
The present findings in combination with existing findings of the literature suggest that ROS and their regulation play a critical role in chondrogenesis. ROS elevation is required for the inhibition of proliferation and induction of hypertrophy in chondrocytes (24) . This could explain the high and low Gpx1 immunoreactivity in proliferating and hypertrophic zones respectively, identified in our study. Moreover, provided that NADPH oxidase 1 and 2 genes are highly expressed in hypertrophic chondrocytes (25) , a reduction in Gpx1 levels during hypertrophy can lead to an elevation of ROS levels and ROS-induced apoptosis of chondrocytes. The present findings are in accordance with this hypothesis.
The spheno-occipital synchondrosis is the last of the synchondroses to ossify and contributes the most to the growth of the cranial base (18) , which in turn influences the development and growth of the craniofacial complex. Therefore, its developmental mechanisms are of importance. In this study, the expression of Gpx1 was identified and localized at the primary cartilage of spheno-occipital synchondrosis for the first time. In addition, Gpx1 is implicated in ROS-induced apoptosis in chondrocytes. This could provide an insight into the role of Gpx1 in chondrogenesis and aims to serve as a stimulus for further research needed to firmly explore its impact on the developmental process of endochondral bone formation.
Conclusions
Gpx1 is expressed at the spheno-occipital synchondrosis with the highest immunoreactivity at the proliferating zones and the lowest one at the hypertrophic zones. It participates in ROS detoxification and, subsequently, ROS-induced apoptosis in chondrocytes. During chondrocyte differentiation, its expression is not of constitutive nature.
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